Empowering Venture Capital Associates

Innovating at the Intersection of Academic Medicine and Venture Capital: A Conversation with Hyung Chun

Featured Guests

  • Hyung-Chun-MD

    Hyung Chun, MD

    Hyung joined Foresite Capital in 2021 as a member of the investment team and focuses on evaluating investment opportunities in private and public biotech companies. Hyung serves as a board member for Latigo Biotherapeutics and a board observer for Odyssey Therapeutics.


    Hyung is a physician scientist from Yale School of Medicine, where he was a tenured faculty member and continues to remain an adjunct faculty. He has published extensively in top scientific and medical journals including Nature, Science, New England Journal of Medicine, Nature Medicine, and Science Translational Medicine, and is an inventor on multiple patents.

On This Episode

On the latest episode of the NextGen VC Podcast, we sit down with Dr. Hyung Chun, Director at Foresite Capital Management. As a seasoned physician-scientist and cardiologist, Dr. Chun brings a unique perspective to the investment landscape, evaluating opportunities and understanding how to drive early discoveries to the clinic. Join us as he shares insights into his steps to become an investor from his tenured faculty position at Yale School of Medicine. We’ll hear about understanding how to learn what you don’t know, the similarities between being a physician-scientist and a venture capitalist, and his vision for the future of biotech. Driven by a passion for advancing medical breakthroughs, Hyung Chun’s episode offers a compelling exploration of the evolving biotech landscape.

Meet the Hosts

Mike Hostetler LaunchBio

Michael Hostetler, JD, PhD - Partner, Wilson Sonsini

Mike is a partner in the San Francisco (SoMa) and San Diego offices of Wilson Sonsini Goodrich & Rosati. He has provided strategic intellectual property counseling to hundreds growth enterprises in the pharmaceutical and biotechnology industries, both venture-backed and public companies. His expertise includes patent strategy, prosecution, and diligence (both buy and sell side) for venture financings, public offerings, mergers and acquisitions.

Jennifer Fang, MEng, JD, Partner, Wilson Sonsini Goodrich & Rosati

Jennifer Fang, JD, M.Eng. - Partner, Wilson Sonsini

Jennifer is a partner in the Boston office of Wilson Sonsini Goodrich & Rosati. She helps innovative startups grow into successful enterprises by providing counsel to the founders, management teams and boards and by handling the legal and strategic business issues and transactions that arise at each stage. She is a member of the National Venture Capital Association (NVCA) General Counsel Advisory Board and is a frequent speaker.

All Episodes


Powered by LaunchBio with generous support from Wilson Sonsini